Evidence map›Paper›PMID 35884754›Full record

ReviewBrain sciences2022

The Prevalence of Dizziness and Vertigo in COVID-19 Patients: A Systematic Review.

George Korres, Dimitrios K Kitsos, Diego Kaski, Anthi Tsogka, Sotirios Giannopoulos, Vasileios Giannopapas, Giorgos Sideris, Giorgos Tyrellis, Konstantine Voumvourakis

Open access · goldAbstract readReview
In one paragraph

Review in Brain sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Neurological complications caused by SARS-CoV-2.Clinical microbiology reviews · 2024
    Review
  10. Article
  11. Article
  12. Article
  13. COVID-19 andAntibiotics (Basel, Switzerland) · 2024
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Neurological manifestation in COVID-19 disease with neuroimaging studies.American journal of neurodegenerative disease · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

George Korres2nd ENT Department, Attikon University Hospital, 124 62 Athens, Greece.
Dimitrios K Kitsos2nd Department of Neurology, Attikon University Hospital, 124 62 Athens, Greece.
Diego KaskiCentre for Vestibular and Behavioural Neuroscience, Department of Clinical and Movement Neurosciences, University College London, 33 Queen Square, London WC1N 3BG, UK.ORCID 0000-0002-0591-646X
Anthi Tsogka2nd Department of Neurology, Attikon University Hospital, 124 62 Athens, Greece.
Sotirios Giannopoulos2nd Department of Neurology, Attikon University Hospital, 124 62 Athens, Greece.
Vasileios Giannopapas2nd Department of Neurology, Laboratory of Neuromuscular & Cardiovascular Study of Motion (LANECASM), Attikon University Hospital, 124 62 Athens, Greece.
Giorgos Sideris2nd ENT Department, Attikon University Hospital, 124 62 Athens, Greece.ORCID 0000-0002-5748-091X
Giorgos Tyrellis2nd ENT Department, Attikon University Hospital, 124 62 Athens, Greece.
Konstantine Voumvourakis2nd Department of Neurology, Attikon University Hospital, 124 62 Athens, Greece.
University General Hospital Attikon · GRNational Hospital for Neurology and Neurosurgery · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clinical manifestations of COVID-19 include symptoms of vertigo and dizziness, which is rather unsurprising, since SARS-CoV-2 neurotropism may inflict a broad spectrum of neuropathic effects. The widespread nature of central and peripheral audiovestibular pathways suggests that there may be several probable pathophysiological mechanisms. The cytokine storm, CNS infiltration of the virus through ACE 2 receptors, and other systemic factors can be responsible for the significant number of COVID-19 patients reported to experience symptoms of vertigo and dizziness. In this paper, we present a systematic review of clinical studies reporting the detection of dizziness and vertigo as clinical manifestations of COVID-19 and discuss their etiopathogenesis.

Indexed as

COVID-19dizzinessreviewvertigo

Identifiers

PMID35884754
PMCPMC9313303
OpenAlexW4286007723

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.